Clinical Trial Update: Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of high-dose irbesartan combined with amlodipine for essential hypertension has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• irbesartan high + amlodipine (irbesartan and amlodipine)

Snippet

Sponsor: Handok Inc. | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED